FDAnews Device Daily Bulletin

SPIRE RECEIVES FDA CLEARANCE TO MARKET COATED LONG-TERM DIALYSIS CATHETER

May 30, 2006
A A

Spire Corporation announced May 25 that it has received clearance from the U.S. Food and Drug Administration (FDA) to market a coated hemodialysis catheter. The coating on this next generation catheter is firmly bonded to both internal and external catheter surfaces, and has demonstrated the ability to reduce thrombus and fibrin sheath formation in both in vitro and animal studies.

Spire (http://phx.corporate-ir.net/phoenix.zhtml?c=76421&p=irol-newsArticle&ID=860900&highlight=)